Immunofluorescence Labeling Indices in Myeloma and Related Monoclonal Gammopathies
- 1 November 1987
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 62 (11), 969-977
- https://doi.org/10.1016/s0025-6196(12)65066-6
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- S-phase detection with an antibody to bromodeoxyuridineJournal of Immunological Methods, 1986
- A monoclonal antibody reactive with a subset of human plasma cellsBritish Journal of Haematology, 1986
- A monoclonal antibody reactive with 5‐bromo‐2‐deoxyuridine that does not require DNA denaturationCytometry, 1985
- Pre-B cells in peripheral blood of multiple myeloma patientsBlood, 1985
- Multiple myeloma: significance of plasmablastic subtype in morphological classificationBlood, 1985
- Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapyBritish Journal of Haematology, 1984
- Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myelomaBlood, 1983
- Ploidy and proliferative characteristics in monoclonal gammopathiesBlood, 1982
- Expansion of Fc receptor-bearing T lymphocytes in patients with immunoglobulin G and immunoglobulin A myeloma.JCI Insight, 1981
- Pretreatment tumor mass, cell kinetics, and prognosis in multiple myelomaBlood, 1980